Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram vs Perphenazine for Agitation in Dementia
NCT00009204Phase 3Completed
- Start
- Sep 1995
- Primary completion
- Apr 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of citalopram in Dementia (3 arms). Primary endpoint: Neurobehavioral Rating Scale (NBRS) Score at 17 days. Started Sep 1995; status: completed.
02
Drugs
citalopram
03
Conditions
Dementia
Beyond the preview
Go deeper on NCT00009204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00009204.